{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:23:07Z","timestamp":1785522187420,"version":"3.56.0"},"reference-count":129,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":61,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05242-3","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T17:12:32Z","timestamp":1779988352000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Artificial intelligence and transforming cancer care"],"prefix":"10.1007","volume":"17","author":[{"given":"Aneesha Mallu","family":"Reddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurleen","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent Sean D.","family":"Ribaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth Laurize A.","family":"Ribaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mallu Chenna","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dheeraj","family":"Shinde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurparsad Singh","family":"Suri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"issue":"3","key":"5242_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"5242_CR2","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.bbcan.2009.11.002","volume":"1805","author":"A Marusyk","year":"2010","unstructured":"Marusyk A, Polyak K. Tumor heterogeneity: causes and consequences. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2010;1805(1):105\u201317. https:\/\/doi.org\/10.1016\/j.bbcan.2009.11.002.","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"},{"issue":"2","key":"5242_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","volume":"15","author":"I Dagogo-Jack","year":"2018","unstructured":"Dagogo-Jack I, Shaw AT. Tumour heterogeneity and resistance to cancer therapies. Nat Rev Clin Oncol. 2018;15(2):81\u201394. https:\/\/doi.org\/10.1038\/nrclinonc.2017.166.","journal-title":"Nat Rev Clin Oncol"},{"issue":"10","key":"5242_CR4","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/nrc3599","volume":"13","author":"C Holohan","year":"2013","unstructured":"Holohan C, Van Schaeybroeck S, Longley DB, Johnston PG. Cancer drug resistance: an evolving paradigm. Nat Rev Cancer. 2013;13(10):714\u201326. https:\/\/doi.org\/10.1038\/nrc3599.","journal-title":"Nat Rev Cancer"},{"issue":"23","key":"5242_CR5","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1056\/NEJMsb1503104","volume":"372","author":"JL Jameson","year":"2015","unstructured":"Jameson JL, Longo DL. Precision medicine \u2014 personalized, problematic, and promising. N Engl J Med. 2015;372(23):2229\u201334. https:\/\/doi.org\/10.1056\/NEJMsb1503104.","journal-title":"N Engl J Med"},{"issue":"21","key":"5242_CR6","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1056\/NEJMoa040938","volume":"350","author":"TJ Lynch","year":"2004","unstructured":"Lynch TJ, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non\u2013small-cell lung cancer to Gefitinib. N Engl J Med. 2004;350(21):2129\u201339. https:\/\/doi.org\/10.1056\/NEJMoa040938.","journal-title":"N Engl J Med"},{"issue":"11","key":"5242_CR7","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1056\/NEJM200103153441101","volume":"344","author":"DJ Slamon","year":"2001","unstructured":"Slamon DJ, et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med. 2001;344(11):783\u201392. https:\/\/doi.org\/10.1056\/NEJM200103153441101.","journal-title":"N Engl J Med"},{"issue":"1","key":"5242_CR8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41591-018-0316-z","volume":"25","author":"A Esteva","year":"2019","unstructured":"Esteva A, et al. A guide to deep learning in healthcare. Nat Med. 2019;25(1):24\u20139. https:\/\/doi.org\/10.1038\/s41591-018-0316-z.","journal-title":"Nat Med"},{"issue":"1","key":"5242_CR9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41591-018-0300-7","volume":"25","author":"EJ Topol","year":"2019","unstructured":"Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nat Med. 2019;25(1):44\u201356. https:\/\/doi.org\/10.1038\/s41591-018-0300-7.","journal-title":"Nat Med"},{"key":"5242_CR10","doi-asserted-by":"publisher","DOI":"10.1177\/10732748241264704","volume":"31","author":"Y Derbal","year":"2024","unstructured":"Derbal Y. Adaptive cancer therapy in the age of generative artificial intelligence. Cancer Control. 2024;31:10732748241264704. https:\/\/doi.org\/10.1177\/10732748241264704.","journal-title":"Cancer Control"},{"issue":"2","key":"5242_CR11","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/path.5310","volume":"249","author":"R Colling","year":"2019","unstructured":"Colling R, et al. Artificial intelligence in digital pathology: a roadmap to routine use in clinical practice. J Pathol. 2019;249(2):143\u201350. https:\/\/doi.org\/10.1002\/path.5310.","journal-title":"J Pathol"},{"issue":"8","key":"5242_CR12","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/s41568-018-0016-5","volume":"18","author":"A Hosny","year":"2018","unstructured":"Hosny A, Parmar C, Quackenbush J, Schwartz LH, Aerts HJWL. Artificial intelligence in radiology. Nat Rev Cancer. 2018;18(8):500\u201310. https:\/\/doi.org\/10.1038\/s41568-018-0016-5.","journal-title":"Nat Rev Cancer"},{"key":"5242_CR13","doi-asserted-by":"publisher","DOI":"10.1177\/10732748221095946","volume":"29","author":"IH Musa","year":"2022","unstructured":"Musa IH, et al. Artificial intelligence and machine learning in cancer research: a systematic and thematic analysis of the top 100 cited articles indexed in Scopus database. Cancer Control. 2022;29:10732748221095946. https:\/\/doi.org\/10.1177\/10732748221095946.","journal-title":"Cancer Control"},{"issue":"4","key":"5242_CR14","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.gendis.2022.02.007","volume":"10","author":"U Anand","year":"2023","unstructured":"Anand U, et al. Cancer chemotherapy and beyond: current status, drug candidates, associated risks and progress in targeted therapeutics. Genes Dis. 2023;10(4):1367\u2013401. https:\/\/doi.org\/10.1016\/j.gendis.2022.02.007.","journal-title":"Genes Dis"},{"issue":"1","key":"5242_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s44276-024-00064-8","volume":"2","author":"R Juthani","year":"2024","unstructured":"Juthani R, Punatar S, Mittra I. New light on chemotherapy toxicity and its prevention. BJC Rep. 2024;2(1):41. https:\/\/doi.org\/10.1038\/s44276-024-00064-8.","journal-title":"BJC Rep"},{"key":"5242_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cegh.2021.100765","volume":"11","author":"SS Arunachalam","year":"2021","unstructured":"Arunachalam SS, et al. Study on knowledge of chemotherapy\u2019s adverse effects and their self-care ability to manage - the cancer survivors impact. Clin Epidemiol Glob Health. 2021;11:100765. https:\/\/doi.org\/10.1016\/j.cegh.2021.100765.","journal-title":"Clin Epidemiol Glob Health"},{"issue":"4","key":"5242_CR17","first-page":"381","volume":"82","author":"FJ Berkey","year":"2010","unstructured":"Berkey FJ. Managing the adverse effects of radiation therapy. Am Fam Physician. 2010;82(4):381\u20138.","journal-title":"Am Fam Physician"},{"issue":"5","key":"5242_CR18","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3322\/caac.21689","volume":"71","author":"K Wang","year":"2021","unstructured":"Wang K, Tepper JE. Radiation therapy\u2010associated toxicity: etiology, management, and prevention. CA Cancer J Clin. 2021;71(5):437\u201354. https:\/\/doi.org\/10.3322\/caac.21689.","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"5242_CR19","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1007\/s00520-014-2235-y","volume":"22","author":"B Yucel","year":"2014","unstructured":"Yucel B, et al. The impact of radiotherapy on quality of life for cancer patients: a longitudinal study. Support Care Cancer. 2014;22(9):2479\u201387. https:\/\/doi.org\/10.1007\/s00520-014-2235-y.","journal-title":"Support Care Cancer"},{"key":"5242_CR20","doi-asserted-by":"publisher","DOI":"10.37689\/acta-ape\/2021AO00583","author":"FM Silveira","year":"2021","unstructured":"Silveira FM, et al. Impacto do tratamento quimioter\u00e1pico na qualidade de vida de pacientes oncol\u00f3gicos. Acta Paul Enferm. 2021. https:\/\/doi.org\/10.37689\/acta-ape\/2021AO00583.","journal-title":"Acta Paul Enferm"},{"key":"5242_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.891652","author":"T Bin Emran","year":"2022","unstructured":"Bin Emran T, et al. Multidrug resistance in cancer: understanding molecular mechanisms,\u00a0immunoprevention and therapeutic approaches. Front Oncol. 2022. https:\/\/doi.org\/10.3389\/fonc.2022.891652.","journal-title":"Front Oncol"},{"issue":"3","key":"5242_CR22","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.3390\/cancers6031769","volume":"6","author":"G Housman","year":"2014","unstructured":"Housman G, et al. Drug resistance in cancer: an overview. Cancers (Basel). 2014;6(3):1769\u201392. https:\/\/doi.org\/10.3390\/cancers6031769.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"5242_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.265","volume":"4","author":"Z-N Lei","year":"2023","unstructured":"Lei Z-N, et al. Understanding and targeting resistance mechanisms in cancer. MedComm. 2023;4(3):e265. https:\/\/doi.org\/10.1002\/mco2.265.","journal-title":"MedComm"},{"issue":"3","key":"5242_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17030441","volume":"17","author":"WJ MacDonald","year":"2025","unstructured":"MacDonald WJ, Purcell C, Pinho-Schwermann M, Stubbs NM, Srinivasan PR, El-Deiry WS. Heterogeneity in cancer. Cancers (Basel). 2025;17(3):441. https:\/\/doi.org\/10.3390\/cancers17030441.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"5242_CR25","doi-asserted-by":"publisher","first-page":"e112","DOI":"10.1016\/j.clbc.2020.08.011","volume":"21","author":"A Tesfaw","year":"2021","unstructured":"Tesfaw A, et al. Late-stage diagnosis and associated factors among breast cancer patients in South and Southwest Ethiopia: a multicenter study. Clin Breast Cancer. 2021;21(1):e112-9. https:\/\/doi.org\/10.1016\/j.clbc.2020.08.011.","journal-title":"Clin Breast Cancer"},{"key":"5242_CR26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4137\/CGM.S31244","volume":"8","author":"S Friberg","year":"2015","unstructured":"Friberg S, Nystr\u00f6m A. Cancer metastases: early dissemination and late recurrences. Cancer Growth Metastasis. 2015;8:43\u20139. https:\/\/doi.org\/10.4137\/CGM.S31244.","journal-title":"Cancer Growth Metastasis"},{"issue":"5","key":"5242_CR27","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013.","journal-title":"Cell"},{"issue":"9","key":"5242_CR28","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1245\/s10434-007-9447-z","volume":"14","author":"AE Giuliano","year":"2007","unstructured":"Giuliano AE, Boolbol S, Degnim A, Kuerer H, Leitch AM, Morrow M. Society of Surgical Oncology: Position statement on prophylactic mastectomy. Ann Surg Oncol. 2007;14(9):2425\u20137. https:\/\/doi.org\/10.1245\/s10434-007-9447-z.","journal-title":"Ann Surg Oncol"},{"key":"5242_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100269","volume":"20","author":"A Desai","year":"2020","unstructured":"Desai A, Gyawali B. Financial toxicity of cancer treatment: moving the discussion from acknowledgement of the problem to identifying solutions. EClinicalMedicine. 2020;20:100269. https:\/\/doi.org\/10.1016\/j.eclinm.2020.100269.","journal-title":"EClinicalMedicine"},{"issue":"3","key":"5242_CR30","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1200\/JCO.2015.62.0468","volume":"34","author":"KR Yabroff","year":"2016","unstructured":"Yabroff KR, et al. Financial hardship associated with cancer in the United States: Findings from a population-based sample of adult cancer survivors. J Clin Oncol. 2016;34(3):259\u201367. https:\/\/doi.org\/10.1200\/JCO.2015.62.0468.","journal-title":"J Clin Oncol"},{"issue":"2","key":"5242_CR31","first-page":"114","volume":"6","author":"IW Mak","year":"2014","unstructured":"Mak IW, Evaniew N, Ghert M. Lost in translation: Animal models and clinical trials in cancer treatment. Am J Transl Res. 2014;6(2):114\u20138.","journal-title":"Am J Transl Res"},{"key":"5242_CR32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1200\/EDBK_100019","volume":"39","author":"F Chino","year":"2019","unstructured":"Chino F, Zafar SY. Financial toxicity and equitable access to clinical trials. Am Soc Clin Oncol Educ Book. 2019;39:11\u20138. https:\/\/doi.org\/10.1200\/EDBK_100019.","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"12","key":"5242_CR33","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1200\/JCO.22.01345","volume":"41","author":"PG Mikhael","year":"2023","unstructured":"Mikhael PG, et al. Sybil: A validated deep learning model to predict future lung cancer risk from a single low-dose chest computed tomography. J Clin Oncol. 2023;41(12):2191\u2013200. https:\/\/doi.org\/10.1200\/JCO.22.01345.","journal-title":"J Clin Oncol"},{"key":"5242_CR34","unstructured":"Ekaterina Pesheva, \u2018New AI tool can diagnose cancer, guide treatment, predict patient survival\u2019, The Harvard Gazette. Accessed: Oct. 12, 2025. [Online]. Available: https:\/\/news.harvard.edu\/gazette\/story\/2024\/09\/new-ai-tool-can-diagnose-cancer-guide-treatment-predict-patient-survival\/"},{"issue":"8035","key":"5242_CR35","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/s41586-024-07894-z","volume":"634","author":"X Wang","year":"2024","unstructured":"Wang X, et al. A pathology foundation model for cancer diagnosis and prognosis prediction. Nature. 2024;634(8035):970\u20138. https:\/\/doi.org\/10.1038\/s41586-024-07894-z.","journal-title":"Nature"},{"issue":"8","key":"5242_CR36","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/S1470-2045(23)00298-X","volume":"24","author":"K L\u00e5ng","year":"2023","unstructured":"L\u00e5ng K, et al. Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study. Lancet Oncol. 2023;24(8):936\u201344. https:\/\/doi.org\/10.1016\/S1470-2045(23)00298-X.","journal-title":"Lancet Oncol"},{"issue":"7788","key":"5242_CR37","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41586-019-1799-6","volume":"577","author":"SM McKinney","year":"2020","unstructured":"McKinney SM, et al. International evaluation of an AI system for breast cancer screening. Nature. 2020;577(7788):89\u201394. https:\/\/doi.org\/10.1038\/s41586-019-1799-6.","journal-title":"Nature"},{"issue":"8","key":"5242_CR38","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/s41591-019-0508-1","volume":"25","author":"G Campanella","year":"2019","unstructured":"Campanella G, et al. Clinical-grade computational pathology using weakly supervised deep learning on whole slide images. Nat Med. 2019;25(8):1301\u20139. https:\/\/doi.org\/10.1038\/s41591-019-0508-1.","journal-title":"Nat Med"},{"issue":"3","key":"5242_CR39","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41379-020-0640-y","volume":"34","author":"W Bulten","year":"2021","unstructured":"Bulten W, et al. Artificial intelligence assistance significantly improves Gleason grading of prostate biopsies by pathologists. Mod Pathol. 2021;34(3):660\u201371. https:\/\/doi.org\/10.1038\/s41379-020-0640-y.","journal-title":"Mod Pathol"},{"key":"5242_CR40","unstructured":"Canadian Agency for Drugs and Technologies in Health, \u2018The Paige Prostate Suite: Assistive Artificial Intelligence for Prostate Cancer Diagnosis: Emerging Health Technologies \u2019. Accessed: Oct. 10, 2025. [Online]. Available: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK608438\/"},{"issue":"1","key":"5242_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48705-3","volume":"15","author":"J Wang","year":"2024","unstructured":"Wang J, et al. Artificial intelligence enables precision diagnosis of cervical cytology grades and cervical cancer. Nat Commun. 2024;15(1):4369. https:\/\/doi.org\/10.1038\/s41467-024-48705-3.","journal-title":"Nat Commun"},{"key":"5242_CR42","unstructured":"RamSoft, \u2018iCAD and RamSoft Announce Partnership to Deliver ProFound\u00ae AI-Powered Mammography Solutions Across North America\u2019, RamSoft Press Release. Accessed: Sep. 09, 2025. [Online]. Available: https:\/\/www.ramsoft.com\/press-releases\/icad-and-ramsoft-announce-partnership-to-deliver-ai-powered-mammography-solutions"},{"issue":"7","key":"5242_CR43","doi-asserted-by":"publisher","first-page":"859","DOI":"10.5858\/arpa.2018-0147-OA","volume":"143","author":"Y Liu","year":"2019","unstructured":"Liu Y, et al. Artificial intelligence\u2013based breast cancer nodal metastasis detection: insights into the black box for pathologists. Arch Pathol Lab Med. 2019;143(7):859\u201368. https:\/\/doi.org\/10.5858\/arpa.2018-0147-OA.","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"5242_CR44","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/s41591-019-0447-x","volume":"25","author":"D Ardila","year":"2019","unstructured":"Ardila D, et al. End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography. Nat Med. 2019;25(6):954\u201361. https:\/\/doi.org\/10.1038\/s41591-019-0447-x.","journal-title":"Nat Med"},{"issue":"1","key":"5242_CR45","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s43856-022-00199-0","volume":"2","author":"D-M Koh","year":"2022","unstructured":"Koh D-M, et al. Artificial intelligence and machine learning in cancer imaging. Commun Med. 2022;2(1):133. https:\/\/doi.org\/10.1038\/s43856-022-00199-0.","journal-title":"Commun Med"},{"issue":"1","key":"5242_CR46","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.intonc.2024.10.003","volume":"1","author":"Y Luo","year":"2025","unstructured":"Luo Y, et al. Multi-omics synergy in oncology: unraveling the complex interplay of radiomic, genoproteomic, and pathological data. Intell Oncol. 2025;1(1):17\u201330. https:\/\/doi.org\/10.1016\/j.intonc.2024.10.003.","journal-title":"Intell Oncol"},{"key":"5242_CR47","doi-asserted-by":"publisher","DOI":"10.1126\/science.adg7492","author":"J Cheng","year":"2023","unstructured":"Cheng J, et al. Accurate proteome-wide missense variant effect prediction with AlphaMissense. Science. 2023. https:\/\/doi.org\/10.1126\/science.adg7492.","journal-title":"Science"},{"issue":"7873","key":"5242_CR48","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper J, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596(7873):583\u20139. https:\/\/doi.org\/10.1038\/s41586-021-03819-2.","journal-title":"Nature"},{"issue":"13","key":"5242_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16132448","volume":"16","author":"Y Ozaki","year":"2024","unstructured":"Ozaki Y, Broughton P, Abdollahi H, Valafar H, Blenda AV. Integrating omics data and AI for cancer diagnosis and prognosis. Cancers. 2024;16(13):2448. https:\/\/doi.org\/10.3390\/cancers16132448.","journal-title":"Cancers"},{"issue":"10","key":"5242_CR50","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/nbt.4235","volume":"36","author":"R Poplin","year":"2018","unstructured":"Poplin R, et al. A universal SNP and small-indel variant caller using deep neural networks. Nat Biotechnol. 2018;36(10):983\u20137. https:\/\/doi.org\/10.1038\/nbt.4235.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"5242_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02426-3","volume":"24","author":"J Le","year":"2025","unstructured":"Le J, et al. Single-cell multi-omics in cancer immunotherapy: from tumor heterogeneity to personalized precision treatment. Mol Cancer. 2025;24(1):221. https:\/\/doi.org\/10.1186\/s12943-025-02426-3.","journal-title":"Mol Cancer"},{"issue":"11","key":"5242_CR52","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1158\/0008-5472.CAN-23-0860","volume":"84","author":"Y Cai","year":"2024","unstructured":"Cai Y, et al. The deep learning framework iCanTCR enables early cancer detection using the T-cell receptor repertoire in peripheral blood. Cancer Res. 2024;84(11):1915\u201328. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-0860.","journal-title":"Cancer Res"},{"key":"5242_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1591696","author":"R Srivastava","year":"2025","unstructured":"Srivastava R. Advancing precision oncology with AI-powered genomic analysis. Front Pharmacol. 2025. https:\/\/doi.org\/10.3389\/fphar.2025.1591696.","journal-title":"Front Pharmacol"},{"issue":"10","key":"5242_CR54","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1158\/1078-0432.CCR-18-3378","volume":"25","author":"E Kawakami","year":"2019","unstructured":"Kawakami E, et al. Application of artificial intelligence for preoperative diagnostic and prognostic prediction in epithelial ovarian cancer based on blood biomarkers. Clin Cancer Res. 2019;25(10):3006\u201315. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-3378.","journal-title":"Clin Cancer Res"},{"issue":"7639","key":"5242_CR55","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nature21056","volume":"542","author":"A Esteva","year":"2017","unstructured":"Esteva A, et al. Dermatologist-level classification of skin cancer with deep neural networks. Nature. 2017;542(7639):115\u20138. https:\/\/doi.org\/10.1038\/nature21056.","journal-title":"Nature"},{"issue":"20","key":"5242_CR56","doi-asserted-by":"publisher","first-page":"5557","DOI":"10.1158\/1078-0432.CCR-21-0325","volume":"27","author":"Y Bai","year":"2021","unstructured":"Bai Y, et al. An open-source, automated tumor-infiltrating lymphocyte algorithm for prognosis in triple-negative breast cancer. Clin Cancer Res. 2021;27(20):5557\u201365. https:\/\/doi.org\/10.1158\/1078-0432.CCR-21-0325.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"5242_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101551","volume":"5","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, et al. Artificial intelligence for diagnosis and prognosis prediction of natural killer\/T cell lymphoma using magnetic resonance imaging. Cell Rep Med. 2024;5(5):101551. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101551.","journal-title":"Cell Rep Med"},{"key":"5242_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1428529","author":"B Ye","year":"2024","unstructured":"Ye B, Li Z, Wang Q. A novel artificial intelligence network to assess the prognosis of gastrointestinal cancer to immunotherapy based on genetic mutation features. Front Immunol. 2024. https:\/\/doi.org\/10.3389\/fimmu.2024.1428529.","journal-title":"Front Immunol"},{"issue":"7","key":"5242_CR59","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/S1470-2045(24)00220-1","volume":"25","author":"A Saha","year":"2024","unstructured":"Saha A, et al. Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI): an international, paired, non-inferiority, confirmatory study. Lancet Oncol. 2024;25(7):879\u201387. https:\/\/doi.org\/10.1016\/S1470-2045(24)00220-1.","journal-title":"Lancet Oncol"},{"key":"5242_CR60","unstructured":"CUSTOM MEDIA for illumina, \u2018Decoding the signs of response to cancer immunotherapy\u2019, Nature Research. Accessed: Sep. 12, 2025. [Online]. Available: https:\/\/www.nature.com\/articles\/d42473-019-00064-0"},{"key":"5242_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/6698969","volume":"2021","author":"BX Elena","year":"2021","unstructured":"Elena BX, Gales LN, Zgura AF, Iliescu L, Anghel RM, Haineala B. Assessment of immune status in dynamics for patients with cancer undergoing immunotherapy. J Oncol. 2021;2021:1\u20137. https:\/\/doi.org\/10.1155\/2021\/6698969.","journal-title":"J Oncol"},{"issue":"16_suppl","key":"5242_CR62","doi-asserted-by":"publisher","first-page":"e14613","DOI":"10.1200\/JCO.2024.42.16_suppl.e14613","volume":"42","author":"V Prasad","year":"2024","unstructured":"Prasad V, Haslam A, Olivier T. Updated estimates of eligibility and response: immune checkpoint inhibitors. J Clin Oncol. 2024;42(16_suppl):e14613\u2013e14613. https:\/\/doi.org\/10.1200\/JCO.2024.42.16_suppl.e14613.","journal-title":"J Clin Oncol"},{"issue":"4","key":"5242_CR63","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.4630","volume":"7","author":"A Yalamanchili","year":"2024","unstructured":"Yalamanchili A, et al. Quality of large language model responses to radiation oncology patient care questions. JAMA Netw Open. 2024;7(4):e244630. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.4630.","journal-title":"JAMA Netw Open"},{"key":"5242_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1119008","author":"SY Chung","year":"2023","unstructured":"Chung SY, Chang JS, Kim YB. Comprehensive clinical evaluation of deep learning-based auto-segmentation for radiotherapy in patients with cervical cancer. Front Oncol. 2023. https:\/\/doi.org\/10.3389\/fonc.2023.1119008.","journal-title":"Front Oncol"},{"key":"5242_CR65","unstructured":"University of Cambridge, \u2018AI cuts waiting times for cancer patients in NHS first\u2019. Accessed: Oct. 12, 2025. [Online]. Available: https:\/\/www.cam.ac.uk\/research\/news\/ai-cuts-waiting-times-for-cancer-patients-in-nhs-first"},{"key":"5242_CR66","unstructured":"Yves Archambault et al.\u00a0Making on-line adaptive radiotherapy possible using artificial intelligence and machine learning for efficient daily re-planning.\u00a0Med Phys Int J.\u00a02020;8(2)."},{"key":"5242_CR67","doi-asserted-by":"publisher","DOI":"10.1002\/acm2.13479","author":"M Byrne","year":"2022","unstructured":"Byrne M, et al. Varian Ethos online adaptive radiotherapy for prostate cancer: Early results of contouring accuracy, treatment plan quality, and treatment time. J Appl Clin Med Phys. 2022. https:\/\/doi.org\/10.1002\/acm2.13479.","journal-title":"J Appl Clin Med Phys"},{"key":"5242_CR68","unstructured":"Elekta, \u2018How AI is revolutionizing healthcare operations\u2019, Focus. Accessed: Aug. 12, 2025. [Online]. Available: https:\/\/www.elekta.com\/focus\/how-ai-is-revolutionizing-healthcare-operations\/"},{"key":"5242_CR69","unstructured":"Elekta, \u2018Maximizing the value of AI and machine learning in cancer treatment\u2019, Focus. Accessed: Sep. 12, 2025. [Online]. Available: https:\/\/www.elekta.com\/focus\/maximizing-the-value-of-ai-and-machine-learning-in-cancer-treatment\/"},{"issue":"4","key":"5242_CR70","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.intonc.2025.09.001","volume":"1","author":"P Xu","year":"2025","unstructured":"Xu P, Liu M, Liu M, Shen A. Artificial intelligence in surgical oncology: a comprehensive review from preoperative planning to postoperative care. Intell Oncol. 2025;1(4):267\u201376. https:\/\/doi.org\/10.1016\/j.intonc.2025.09.001.","journal-title":"Intell Oncol"},{"issue":"5","key":"5242_CR71","doi-asserted-by":"publisher","DOI":"10.3348\/kjr.2011.12.5.588","volume":"12","author":"SY Kim","year":"2011","unstructured":"Kim SY, et al. Pre-operative prediction of advanced prostatic cancer using clinical decision support systems: Accuracy comparison between support vector machine and artificial neural network. Korean J Radiol. 2011;12(5):588. https:\/\/doi.org\/10.3348\/kjr.2011.12.5.588.","journal-title":"Korean J Radiol"},{"issue":"7","key":"5242_CR72","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.jacr.2018.12.017","volume":"16","author":"Q-X Feng","year":"2019","unstructured":"Feng Q-X, et al. An intelligent clinical decision support system for preoperative prediction of lymph node metastasis in gastric cancer. J Am Coll Radiol. 2019;16(7):952\u201360. https:\/\/doi.org\/10.1016\/j.jacr.2018.12.017.","journal-title":"J Am Coll Radiol"},{"issue":"1","key":"5242_CR73","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41591-019-0715-9","volume":"26","author":"TC Hollon","year":"2020","unstructured":"Hollon TC, et al. Near real-time intraoperative brain tumor diagnosis using stimulated Raman histology and deep neural networks. Nat Med. 2020;26(1):52\u20138. https:\/\/doi.org\/10.1038\/s41591-019-0715-9.","journal-title":"Nat Med"},{"issue":"10","key":"5242_CR74","doi-asserted-by":"publisher","first-page":"7759","DOI":"10.1007\/s00432-023-04713-2","volume":"149","author":"Z-R Zhao","year":"2023","unstructured":"Zhao Z-R, et al. Invasiveness assessment by artificial intelligence against intraoperative frozen section for pulmonary nodules\u2009\u2264\u20093\u00a0cm. J Cancer Res Clin Oncol. 2023;149(10):7759\u201365. https:\/\/doi.org\/10.1007\/s00432-023-04713-2.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"5242_CR75","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.spinee.2023.09.001","volume":"24","author":"X Shi","year":"2024","unstructured":"Shi X, Cui Y, Wang S, Pan Y, Wang B, Lei M. Development and validation of a web-based artificial intelligence prediction model to assess massive intraoperative blood loss for metastatic spinal disease using machine learning techniques. Spine J. 2024;24(1):146\u201360. https:\/\/doi.org\/10.1016\/j.spinee.2023.09.001.","journal-title":"Spine J"},{"issue":"10","key":"5242_CR76","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1007\/s00259-024-06731-9","volume":"51","author":"PA Boland","year":"2024","unstructured":"Boland PA, et al. Intraoperative near infrared functional imaging of rectal cancer using artificial intelligence methods - now and near future state of the art. Eur J Nucl Med Mol Imaging. 2024;51(10):3135\u201348. https:\/\/doi.org\/10.1007\/s00259-024-06731-9.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5242_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2024.1452223","author":"D Andras","year":"2024","unstructured":"Andras D, et al. Analyzing postoperative complications in colorectal cancer surgery: a systematic review enhanced by artificial intelligence. Front Surg. 2024. https:\/\/doi.org\/10.3389\/fsurg.2024.1452223.","journal-title":"Front Surg"},{"issue":"1","key":"5242_CR78","doi-asserted-by":"publisher","DOI":"10.1186\/s43055-024-01272-5","volume":"55","author":"S Mansour","year":"2024","unstructured":"Mansour S, Azzam H, El-Assaly H. Artificial intelligence as a negative predictive tool for breast cancer postoperative recurrence. Egypt J Radiol Nucl Med. 2024;55(1):102. https:\/\/doi.org\/10.1186\/s43055-024-01272-5.","journal-title":"Egypt J Radiol Nucl Med"},{"issue":"3","key":"5242_CR79","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1080\/10255842.2023.2292009","volume":"28","author":"J Gong","year":"2025","unstructured":"Gong J, Ye P, Chang Z. The application of lightweight AI algorithms in postoperative rehabilitation of breast cancer. Comput Methods Biomech Biomed Engin. 2025;28(3):398\u2013409. https:\/\/doi.org\/10.1080\/10255842.2023.2292009.","journal-title":"Comput Methods Biomech Biomed Engin"},{"issue":"5","key":"5242_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e26580","volume":"10","author":"C-M Zhou","year":"2024","unstructured":"Zhou C-M, Li H, Xue Q, Yang J-J, Zhu Y. Artificial intelligence algorithms for predicting post-operative ileus after laparoscopic surgery. Heliyon. 2024;10(5):e26580. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e26580.","journal-title":"Heliyon"},{"issue":"1","key":"5242_CR81","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s10330-022-0557-7","volume":"8","author":"T Qin","year":"2022","unstructured":"Qin T, Chen G. Recent advances in targeted therapy for ovarian cancer. Oncol Transl Med. 2022;8(1):28\u201335. https:\/\/doi.org\/10.1007\/s10330-022-0557-7.","journal-title":"Oncol Transl Med"},{"issue":"2","key":"5242_CR82","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/ot9.0000000000000074","volume":"11","author":"X Zhou","year":"2025","unstructured":"Zhou X, Wang X, Yang S, Huang Z. Advances in immunotherapy and targeted therapy for pancreatic cancer. Oncol Transl Med. 2025;11(2):81\u201391. https:\/\/doi.org\/10.1097\/ot9.0000000000000074.","journal-title":"Oncol Transl Med"},{"issue":"4","key":"5242_CR83","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1097\/SLA.0000000000006279","volume":"281","author":"W Li","year":"2025","unstructured":"Li W, et al. Noninvasive artificial intelligence system for early predicting residual cancer burden during neoadjuvant chemotherapy in breast cancer. Ann Surg. 2025;281(4):645\u201354. https:\/\/doi.org\/10.1097\/SLA.0000000000006279.","journal-title":"Ann Surg"},{"issue":"3","key":"5242_CR84","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1002\/mp.15437","volume":"49","author":"C Li","year":"2022","unstructured":"Li C, et al. Deep learning\u2010based AI model for signet\u2010ring cell carcinoma diagnosis and chemotherapy response prediction in gastric cancer. Med Phys. 2022;49(3):1535\u201346. https:\/\/doi.org\/10.1002\/mp.15437.","journal-title":"Med Phys"},{"issue":"11","key":"5242_CR85","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering11111172","volume":"11","author":"J Finkelstein","year":"2024","unstructured":"Finkelstein J, Smiley A, Echeverria C, Mooney K. AI-driven prediction of symptom trajectories in cancer care: a deep learning approach for chemotherapy management. Bioengineering (Basel). 2024;11(11):1172. https:\/\/doi.org\/10.3390\/bioengineering11111172.","journal-title":"Bioengineering (Basel)"},{"issue":"16","key":"5242_CR86","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14164012","volume":"14","author":"V Russo","year":"2022","unstructured":"Russo V, et al. Artificial intelligence predictive models of response to cytotoxic chemotherapy alone or combined to targeted therapy for metastatic colorectal cancer patients: a systematic review and meta-analysis. Cancers (Basel). 2022;14(16):4012. https:\/\/doi.org\/10.3390\/cancers14164012.","journal-title":"Cancers (Basel)"},{"issue":"20","key":"5242_CR87","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.1158\/1078-0432.CCR-24-1265","volume":"30","author":"YH Bang","year":"2024","unstructured":"Bang YH, et al. Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes as a potential biomarker for immune checkpoint inhibitors in patients with biliary tract cancer. Clin Cancer Res. 2024;30(20):4635\u201343. https:\/\/doi.org\/10.1158\/1078-0432.CCR-24-1265.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"5242_CR88","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1177\/2472630319890316","volume":"25","author":"A Blasiak","year":"2020","unstructured":"Blasiak A, Khong J, Kee T. CURATE.AI: optimizing personalized medicine with artificial intelligence. SLAS Technol. 2020;25(2):95\u2013105. https:\/\/doi.org\/10.1177\/2472630319890316.","journal-title":"SLAS Technol"},{"issue":"16_suppl","key":"5242_CR89","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1200\/JCO.2022.40.16_suppl.1574","volume":"40","author":"A Blasiak","year":"2022","unstructured":"Blasiak A, et al. Precise CURATE.AI: a prospective feasibility trial to dynamically modulate personalized chemotherapy dose with artificial intelligence. J Clin Oncol. 2022;40(16_suppl):1574\u20131574. https:\/\/doi.org\/10.1200\/JCO.2022.40.16_suppl.1574.","journal-title":"J Clin Oncol"},{"key":"5242_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.117164","volume":"284","author":"S Ambreen","year":"2025","unstructured":"Ambreen S, Umar M, Noor A, Jain H, Ali R. Advanced AI and ML frameworks for transforming drug discovery and optimization: with innovative insights in polypharmacology, drug repurposing, combination therapy and nanomedicine. Eur J Med Chem. 2025;284:117164. https:\/\/doi.org\/10.1016\/j.ejmech.2024.117164.","journal-title":"Eur J Med Chem"},{"key":"5242_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2025.104653","volume":"208","author":"M Shirzad","year":"2025","unstructured":"Shirzad M, et al. Revolutionizing prostate cancer therapy: artificial intelligence \u2013 based nanocarriers for precision diagnosis and treatment. Crit Rev Oncol Hematol. 2025;208:104653. https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104653.","journal-title":"Crit Rev Oncol Hematol"},{"key":"5242_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.artmed.2019.07.001","volume":"99","author":"N Houy","year":"2019","unstructured":"Houy N, Le Grand F. Personalized oncology with artificial intelligence: the case of temozolomide. Artif Intell Med. 2019;99:101693. https:\/\/doi.org\/10.1016\/j.artmed.2019.07.001.","journal-title":"Artif Intell Med"},{"issue":"2","key":"5242_CR93","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1001\/jamaoncol.2024.5356","volume":"11","author":"M Rakaee","year":"2025","unstructured":"Rakaee M, et al. Deep learning model for predicting immunotherapy response in advanced non\u2212small cell lung cancer. JAMA Oncol. 2025;11(2):109. https:\/\/doi.org\/10.1001\/jamaoncol.2024.5356.","journal-title":"JAMA Oncol"},{"issue":"10","key":"5242_CR94","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/s43018-022-00416-8","volume":"3","author":"RS Vanguri","year":"2022","unstructured":"Vanguri RS, et al. Multimodal integration of radiology, pathology and genomics for prediction of response to PD-(L)1 blockade in patients with non-small cell lung cancer. Nat Cancer. 2022;3(10):1151\u201364. https:\/\/doi.org\/10.1038\/s43018-022-00416-8.","journal-title":"Nat Cancer"},{"issue":"8","key":"5242_CR95","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1038\/s43018-024-00772-7","volume":"5","author":"T-G Chang","year":"2024","unstructured":"Chang T-G, et al. LORIS robustly predicts patient outcomes with immune checkpoint blockade therapy using common clinical, pathologic and genomic features. Nat Cancer. 2024;5(8):1158\u201375. https:\/\/doi.org\/10.1038\/s43018-024-00772-7.","journal-title":"Nat Cancer"},{"key":"5242_CR96","unstructured":"Sharon Reynolds, \u2018Can AI Help Predict Which Cancer Patients Should Be Treated with Immunotherapy?\u2019, National Cancer Institute. Accessed: Feb. 10, 2026. [Online]. Available: https:\/\/www.cancer.gov\/news-events\/cancer-currents-blog\/2025\/ai-predicts-cancer-immunotherapy-response-survival"},{"key":"5242_CR97","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18564","author":"B Ye","year":"2024","unstructured":"Ye B, et al. Deciphering lung adenocarcinoma prognosis and immunotherapy response through an AI\u2010driven stemness\u2010related gene signature. J Cell Mol Med. 2024. https:\/\/doi.org\/10.1111\/jcmm.18564.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"5242_CR98","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-58684-6","volume":"14","author":"H Peng","year":"2024","unstructured":"Peng H, Moore C, Zhang Y, Saha D, Jiang S, Timmerman R. An AI-based approach for modeling the synergy between radiotherapy and immunotherapy. Sci Rep. 2024;14(1):8250. https:\/\/doi.org\/10.1038\/s41598-024-58684-6.","journal-title":"Sci Rep"},{"issue":"12","key":"5242_CR99","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1158\/1078-0432.CCR-19-1744","volume":"26","author":"F Xie","year":"2020","unstructured":"Xie F, et al. Multifactorial deep learning reveals pan-cancer genomic tumor clusters with distinct immunogenomic landscape and response to immunotherapy. Clin Cancer Res. 2020;26(12):2908\u201320. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-1744.","journal-title":"Clin Cancer Res"},{"key":"5242_CR100","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1200\/CCI.20.00107","volume":"5","author":"A Gupta","year":"2021","unstructured":"Gupta A, et al. Risk prediction using Bayesian networks: an immunotherapy case study in patients with metastatic renal cell carcinoma. JCO Clin Cancer Inform. 2021;5:326\u201337. https:\/\/doi.org\/10.1200\/CCI.20.00107.","journal-title":"JCO Clin Cancer Inform"},{"issue":"12","key":"5242_CR101","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1002\/cncr.35307","volume":"130","author":"L Kolla","year":"2024","unstructured":"Kolla L, Parikh RB. Uses and limitations of artificial intelligence for oncology. Cancer. 2024;130(12):2101\u20137. https:\/\/doi.org\/10.1002\/cncr.35307.","journal-title":"Cancer"},{"issue":"1","key":"5242_CR102","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41416-021-01633-1","volume":"126","author":"C Luchini","year":"2022","unstructured":"Luchini C, Pea A, Scarpa A. Artificial intelligence in oncology: current applications and future perspectives. Br J Cancer. 2022;126(1):4\u20139. https:\/\/doi.org\/10.1038\/s41416-021-01633-1.","journal-title":"Br J Cancer"},{"issue":"1","key":"5242_CR103","doi-asserted-by":"publisher","first-page":"e64","DOI":"10.1016\/S2589-7500(21)00252-1","volume":"4","author":"D Wen","year":"2022","unstructured":"Wen D, et al. Characteristics of publicly available skin cancer image datasets: a systematic review. Lancet Digit Health. 2022;4(1):e64-74. https:\/\/doi.org\/10.1016\/S2589-7500(21)00252-1.","journal-title":"Lancet Digit Health"},{"key":"5242_CR104","unstructured":"A. Morales-Forero, L. J. Rueda, R. Herrera, S. Bassetto, and E. Coatanea, \u2018Predictive Representativity: Uncovering Racial Bias in AI-based Skin Cancer Detection\u2019, Jul. 2025, Accessed: Oct. 17, 2025. [Online]. Available: https:\/\/arxiv.org\/abs\/2507.14176"},{"issue":"6","key":"5242_CR105","doi-asserted-by":"publisher","first-page":"302","DOI":"10.37349\/edht.2024.00030","volume":"2","author":"K Ding","year":"2024","unstructured":"Ding K, Forbes S, Ma F, Luo G, Zhou J, Qi Y. AI bias in lung cancer radiotherapy. Exploration of Digital Health Technologies. 2024;2(6):302\u201312. https:\/\/doi.org\/10.37349\/edht.2024.00030.","journal-title":"Exploration of Digital Health Technologies"},{"key":"5242_CR106","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.61012","author":"SC Pokhriyal","year":"2024","unstructured":"Pokhriyal SC, Shukla A, Gupta U, Al-Ghuraibawi MMH, Yadav R, Panigrahi K. Application of artificial intelligence in neuroendocrine lung cancer diagnosis and treatment: a systematic review. Cureus. 2024. https:\/\/doi.org\/10.7759\/cureus.61012.","journal-title":"Cureus"},{"key":"5242_CR107","doi-asserted-by":"publisher","DOI":"10.1177\/03000605211000157","author":"L Jiang","year":"2021","unstructured":"Jiang L, et al. Opportunities and challenges of artificial intelligence in the medical field: current application, emerging problems, and problem-solving strategies. J Int Med Res. 2021. https:\/\/doi.org\/10.1177\/03000605211000157.","journal-title":"J Int Med Res"},{"issue":"3","key":"5242_CR108","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.urolonc.2023.11.019","volume":"42","author":"BZ Wubineh","year":"2024","unstructured":"Wubineh BZ, Deriba FG, Woldeyohannis MM. Exploring the opportunities and challenges of implementing artificial intelligence in healthcare: a systematic literature review. Urol Oncol. 2024;42(3):48\u201356. https:\/\/doi.org\/10.1016\/j.urolonc.2023.11.019.","journal-title":"Urol Oncol"},{"issue":"2","key":"5242_CR109","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s44174-023-00063-2","volume":"1","author":"B khan","year":"2023","unstructured":"khan B, et al. Drawbacks of artificial intelligence and their potential solutions in the healthcare sector. Biomed Mater Devices. 2023;1(2):731\u20138. https:\/\/doi.org\/10.1007\/s44174-023-00063-2.","journal-title":"Biomed Mater Devices"},{"key":"5242_CR110","doi-asserted-by":"publisher","DOI":"10.3389\/frai.2022.879603","author":"A Kiseleva","year":"2022","unstructured":"Kiseleva A, Kotzinos D, De Hert P. Transparency of AI in healthcare as a multilayered system of accountabilities: between legal requirements and technical limitations. Front Artif Intell. 2022. https:\/\/doi.org\/10.3389\/frai.2022.879603.","journal-title":"Front Artif Intell"},{"key":"5242_CR111","doi-asserted-by":"publisher","first-page":"72","DOI":"10.4018\/979-8-3693-5468-1.ch005","volume-title":"Challenges and limitations of explainable AI in healthcare","author":"V Grover","year":"2024","unstructured":"Grover V, Dogra M. Challenges and limitations of explainable AI in healthcare: In: Challenges and limitations of explainable AI in healthcare. 2024. p. 72\u201385. https:\/\/doi.org\/10.4018\/979-8-3693-5468-1.ch005."},{"key":"5242_CR112","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/B978-0-443-15504-8.00008-9","volume-title":"Artificial intelligence in urologic malignancies","author":"D Van Booven","year":"2025","unstructured":"Van Booven D, Cheng-Bang C, Meenakshy M. Limitations of artificial intelligence in healthcare. In: Artificial intelligence in urologic malignancies. Elsevier; 2025. p. 231\u201346. https:\/\/doi.org\/10.1016\/B978-0-443-15504-8.00008-9."},{"issue":"1","key":"5242_CR113","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25858-z","volume":"12","author":"M Perkonigg","year":"2021","unstructured":"Perkonigg M, et al. Dynamic memory to alleviate catastrophic forgetting in continual learning with medical imaging. Nat Commun. 2021;12(1):5678. https:\/\/doi.org\/10.1038\/s41467-021-25858-z.","journal-title":"Nat Commun"},{"key":"5242_CR114","unstructured":"Yavari S, Furst J. Mitigating Catastrophic Forgetting in the Incremental Learning of Medical Images. arXiv preprint arXiv:2504.20033, 2025."},{"key":"5242_CR115","unstructured":"Baweja C, Glocker B, Kamnitsas K. Towards continual learning in medical imaging\u2019, ArXiv. Accessed: Aug. 12, 2025. [Online]. Available: https:\/\/api.semanticscholar.org\/CorpusID:53234376."},{"key":"5242_CR116","doi-asserted-by":"publisher","DOI":"10.1177\/10732748251349919","volume":"32","author":"Y Derbal","year":"2025","unstructured":"Derbal Y. Generative AI - assisted adaptive cancer therapy. Cancer Control. 2025;32:10732748251349920. https:\/\/doi.org\/10.1177\/10732748251349919.","journal-title":"Cancer Control"},{"issue":"10","key":"5242_CR117","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.annonc.2023.08.008","volume":"34","author":"MAR Strobl","year":"2023","unstructured":"Strobl MAR, Gallaher J, Robertson-Tessi M, West J, Anderson ARA. Treatment of evolving cancers will require dynamic decision support. Ann Oncol. 2023;34(10):867\u201384. https:\/\/doi.org\/10.1016\/j.annonc.2023.08.008.","journal-title":"Ann Oncol"},{"issue":"1","key":"5242_CR118","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06641-w","volume":"23","author":"T Zhang","year":"2025","unstructured":"Zhang T, et al. Spatial-temporal radiogenomics in predicting neoadjuvant chemotherapy efficacy for breast cancer: a comprehensive review. J Transl Med. 2025;23(1):681. https:\/\/doi.org\/10.1186\/s12967-025-06641-w.","journal-title":"J Transl Med"},{"key":"5242_CR119","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1594450","author":"Y Li","year":"2025","unstructured":"Li Y, Yi X, Fu J, Yang Y, Duan C, Wang J. Reducing misdiagnosis in AI-driven medical diagnostics: a multidimensional framework for technical, ethical, and policy solutions. Front Med. 2025. https:\/\/doi.org\/10.3389\/fmed.2025.1594450.","journal-title":"Front Med"},{"key":"5242_CR120","doi-asserted-by":"publisher","DOI":"10.2196\/76854","volume":"4","author":"E Carvalho","year":"2025","unstructured":"Carvalho E, et al. Predetermined change control plans: guiding principles for advancing safe, effective, and high-quality AI-ML technologies. JMIR AI. 2025;4:e76854\u2013e76854. https:\/\/doi.org\/10.2196\/76854.","journal-title":"JMIR AI"},{"key":"5242_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.medengphy.2025.104405","volume":"144","author":"A Akg\u00fcndo\u011fdu","year":"2025","unstructured":"Akg\u00fcndo\u011fdu A, \u00c7elikba\u015f \u015e. Explainable deep learning framework for brain tumor detection: integrating LIME, Grad-CAM, and SHAP for enhanced accuracy. Med Eng Phys. 2025;144:104405. https:\/\/doi.org\/10.1016\/j.medengphy.2025.104405.","journal-title":"Med Eng Phys"},{"issue":"3","key":"5242_CR122","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.4077","volume":"7","author":"A Hantel","year":"2024","unstructured":"Hantel A, et al. Perspectives of oncologists on the ethical implications of using artificial intelligence for cancer care. JAMA Netw Open. 2024;7(3):e244077. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.4077.","journal-title":"JAMA Netw Open"},{"key":"5242_CR123","unstructured":"Schubert Jonckheer & Kolbe LLP, \u2018PRIVACY ALERT: Integrated Oncology Network Under Investigation for Data Breach of Over 113,000 Patient Records\u2019, PR Newswire. Accessed: Aug. 15, 2025. [Online]. Available: https:\/\/www.prnewswire.com\/news-releases\/privacy-alert-integrated-oncology-network-under-investigation-for-data-breach-of-over-113-000-patient-records-302500864.html"},{"key":"5242_CR124","unstructured":"Jacob Hansen, Kelly Carlin, Anna Hart, Jody Johnson, Scott Wells, and Joan M. Kiel, \u2018Updating HIPAA Security to Respond to Artificial Intelligence\u2019, J Ahima. Accessed: Sep. 19, 2025. [Online]. Available: https:\/\/journal.ahima.org\/page\/updating-hipaa-security-to-respond-to-artificial-intelligence"},{"issue":"17","key":"5242_CR125","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare13172154","volume":"13","author":"Q Abbas","year":"2025","unstructured":"Abbas Q, Jeong W, Lee SW. Explainable AI in clinical decision support systems: a meta-analysis of methods, applications, and usability challenges. Healthcare. 2025;13(17):2154. https:\/\/doi.org\/10.3390\/healthcare13172154.","journal-title":"Healthcare"},{"issue":"3","key":"5242_CR126","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.3390\/curroncol30030260","volume":"30","author":"BP Cabral","year":"2023","unstructured":"Cabral BP, Braga LAM, Syed-Abdul S, Mota FB. Future of artificial intelligence applications in cancer care: a global cross-sectional survey of researchers. Curr Oncol. 2023;30(3):3432\u201346. https:\/\/doi.org\/10.3390\/curroncol30030260.","journal-title":"Curr Oncol"},{"issue":"1","key":"5242_CR127","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-023-01514-5","volume":"16","author":"C Zhang","year":"2023","unstructured":"Zhang C, et al. Novel research and future prospects of artificial intelligence in cancer diagnosis and treatment. J Hematol Oncol. 2023;16(1):114. https:\/\/doi.org\/10.1186\/s13045-023-01514-5.","journal-title":"J Hematol Oncol"},{"issue":"36","key":"5242_CR128","doi-asserted-by":"publisher","first-page":"5408","DOI":"10.3748\/wjg.v26.i36.5408","volume":"26","author":"P-H Niu","year":"2020","unstructured":"Niu P-H, Zhao L-L, Wu H-L, Zhao D-B, Chen Y-T. Artificial intelligence in gastric cancer: application and future perspectives. World J Gastroenterol. 2020;26(36):5408\u201319. https:\/\/doi.org\/10.3748\/wjg.v26.i36.5408.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"5242_CR129","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00439-019-01970-5","volume":"138","author":"J Xu","year":"2019","unstructured":"Xu J, et al. Translating cancer genomics into precision medicine with artificial intelligence: applications, challenges and future perspectives. Hum Genet. 2019;138(2):109\u201324. https:\/\/doi.org\/10.1007\/s00439-019-01970-5.","journal-title":"Hum Genet"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05242-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05242-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05242-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:11:59Z","timestamp":1785517919000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05242-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":129,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5242"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05242-3","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"25 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. This article is a review of existing literature and did not involve direct participation of human subjects or animal research by the authors. All data discussed are from previously published studies. Not applicable. This study did not involve the recruitment of human participants or the collection of primary data.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. No individual patient data, identifiable images, or personal details are included in this manuscript that would require specific patient consent for publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1086"}}